PT - JOURNAL ARTICLE AU - Singh, Ambrish AU - Jones, Graeme AU - Ding, Changhai AU - Winzenberg, Tania AU - Cicuttini, Flavia AU - Lavekar, Swati AU - Molina-Garcia, Pablo AU - Otahal, Petr AU - Antony, Benny TI - Early life modifiable risk factors for the development of knee osteoarthritis: protocol for a systematic review AID - 10.1101/2020.05.24.20112250 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.24.20112250 4099 - http://medrxiv.org/content/early/2020/05/25/2020.05.24.20112250.short 4100 - http://medrxiv.org/content/early/2020/05/25/2020.05.24.20112250.full AB - Knee osteoarthritis (OA) is the most common form of OA which affects knee joints and there is currently no disease-modifying treatment available for OA. Therefore, an ideal strategy to prevent the development of OA is to identify and intervene at the modifiable risk factors for the development and progression of OA. Early-life factors such as obesity and malalignment may affect the mechanical aspect of the knee (i.e. alterations in normal knee kinematics) and could be the risk factor for the development of knee OA in later life. Identifying early-life (gestational factors, congenital defects, childhood, adolescence, early adulthood) factors which affect the development of knee OA in later stages of the life may help to develop targeted prevention programs in early-life itself to prevent the development of knee OA. Hence, this systematic review protocol provides the method to be used to comprehensively summarise the existing evidence on early life modifiable risk factors associated with the development and progression of knee OA.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot applicable